A phase I Study of ecteinascidin 743(E) and capecitabine (C) in patients (pts) with advanced solid malignancies.

被引：0
|
作者：
Holden, SN
Rivera, E
Basche, M
Gore, L
Raj, SKS
O'Bryant, CL
Grolnic, S
Hunt, J
Brillhart, B
Van de Velde, H
Roberts, D
Rodgers, J
Eckhardt, SG
机构：
[1] Univ Colorado, Ctr Canc, Denver, CO 80202 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Johnson & Johnson Pharmaceut R&D, Beerse, Belgium
[4] Johnson & Johnson Pharmaceut R&D, Titusville, NJ USA
来源：
CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6080S / 6080S
页数：1
相关论文
共 50 条
  • [41] Brequinar in combination with cisplatin in patients with advanced malignancies. A phase I study with pharmacokinetics
    Burris, A
    Raymond, E
    Awada, A
    Kuhn, J
    O'Rourke, J
    Brentzel, J
    Lynch, W
    King, SY
    Brown, T
    Von Hoff, D
    ANNALS OF ONCOLOGY, 1998, 9 : 125 - 125
  • [42] Phase I trial of paclitaxel, bevacizumab, and temsirolimus in advanced solid malignancies.
    Westin, Shannon Neville
    Stashi, Erin
    Pal, Navdeep
    Urbauer, Diana L.
    Janku, Filip
    Piha-Paul, Sarina Anne
    Naing, Aung
    Tsimberidou, Apostolia Maria
    Fu, Siqing
    Hong, David S.
    Subbiah, Vivek
    Karp, Daniel D.
    Coleman, Robert L.
    Meric-Bernstam, Funda
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] Phase I trial of SU014813 in patients (pts) with advanced solid malignancies
    Fiedler, W. M.
    Giaccone, G.
    Lasch, P.
    Van der Horst, I.
    Brega, N. M.
    Raber, S.
    Shalinsky, D.
    Ljubmir, V.
    Bokemeyer, C.
    Boven, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] Phase I tolerability/safety of sunitinib in combination with capecitabine in patients (pts) with advanced solid tumors
    Verschraegen, C.
    Sweeney, C.
    Chiorean, G.
    Lee, F. C.
    Jones, S.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H., III
    EJC SUPPLEMENTS, 2007, 5 (04): : 111 - 111
  • [45] Phase I study combining MLN8237 with nab-paclitaxel in patients with advanced solid malignancies.
    Lim, Kian-Huat
    Lockhart, Albert C.
    Waqar, Saiama Naheed
    Govindan, Ramaswamy
    Baggstrom, Maria Quintos
    Wang-Gillam, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [46] Phase I study combining MLN8237 with nab-paclitaxel in patients with advanced solid malignancies.
    Lim, Kian-Huat
    Lockhart, Albert C.
    Waqar, Saiama Naheed
    Govindan, Ramaswamy
    Morgensztern, Daniel
    Picus, Joel
    Tan, Benjamin R.
    Baggstrom, Maria Quintos
    Ratchford, Emily
    Marquez, Samantha
    Wang-Gillam, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Phase I trial of gemcitabine and epirubicin in patients with solid malignancies.
    Mahadevan, D
    Dreisbach, L
    Williams, D
    Pilkington, D
    Gebremarium, C
    Martin, E
    Obregon, Y
    Von Hoff, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 360S - 360S
  • [48] Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies
    Ramanathan, RK
    Ramalingam, S
    Egorin, MJ
    Belani, CP
    Potter, DM
    Fakih, M
    Jung, LL
    Strychor, S
    Jacobs, SA
    Friedland, DM
    Shin, DM
    Chatta, GS
    Tutchko, S
    Zamboni, WC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (04) : 354 - 360
  • [49] Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies
    Ramesh K. Ramanathan
    Sakkaraiappan Ramalingam
    Merrill J. Egorin
    Chandra P. Belani
    Douglas M. Potter
    Marwan Fakih
    Laura L. Jung
    Sandra Strychor
    Samuel A. Jacobs
    David M. Friedland
    Dong M. Shin
    Gurkamal S. Chatta
    Susan Tutchko
    William C. Zamboni
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 354 - 360
  • [50] Phase I trial of BMS-247550 and gemcitabine in patients with advanced solid tumor malignancies.
    Anderson, S
    Dizon, D
    Sabbatini, P
    Dupont, J
    Pezzulli, S
    Massey, A
    Aghajanian, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 151S - 151S
12345